Introduction
Innate immune system, which directs the subsequent development of adaptive immune responses, recognizes the pathogen as non-self by Toll-like receptors (TLRs) and eliminates them while inducing inflammatory response [1] . Activation of the innate immune system via the TLR is negatively regulated by various mechanisms, as overactivity causes various systemic inflammatory diseases. In fact, it has been shown that IκBNS (also known as IκB-δ, or Nfkbid: nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor, delta) of nuclear molecule induced by TLR stimulation negatively regulates TLRdependent subset gene expression by suppressing the activity of nuclear factor-κB (NF-κB) [2, 3] . In the unstimulated state, NF-κB (p50/ p65 heterodimer) binds to its inhibitory molecule IκBα and exists as an inactive form in the cytoplasm [4] [5] [6] [7] . However, if inflammatory triggers such as lipopolysaccharide (LPS) are recognized by TLR, degradation of IκBα is induced and it turns into active NF-κB [8, 9] . Active NF-κB translocates into the nucleus, binds to the promoter region of various inflammatory mediators, and initiates its transcription [2, 10] . IκBNS specifically inhibits the binding of activated NF-κB to the promoter region of interleukin-6 (IL-6) [11] . Atherosclerosis has long been recognized as chronic inflammatory disease [12] [13] [14] [15] . Several TLRs have been shown to be associated with inflammatory activation in human atherosclerotic lesions [16] . In particular, TLR4 expression in mouse and human atherosclerotic lesions was observed [16] [17] [18] , and it was confirmed that lack of TLR4 has decreased atherosclerotic lesions in apolipoprotein E-deficient (apoE −/− ) mice [19] . LPS acts as extremely strong stimulator of innate immunity. We tried to investigate whether stimulation of innate immunity could promote atherosclerosis in the IκBNS-deficient atherogenic mice. However all IκBNS-deficient mice died within 4 days of LPS challenge at a dose of which almost all wild-type mice survived over 4 days, because IκBNS-deficient mice are highly sensitive to LPS-induced endotoxin shock [3] . Then, we decided to use a cholate-containing high fat diet (HFD(CA (+))) such as the Paigen diet, which has been widely used as an atherogenic diet in mice to promote fat and cholesterol absorption [20, 21] . Moreover, cholate also has a role as a signaling molecule involved in inflammation, indeed a kind of HFD(CA(+)) (Paigen diet) has been shown to induce TLR4 mediated early inflammatory response [22] . Furthermore, other kind of HFD(CA(+)) (Paigen diet) increased TLR4 expression in atherosclerotic lesions of apoE −/− mice [23] .
Therefore, we examined to clarify that the stimulation of innate immunity using HFD(CA(+)) promotes atherogenesis in the IκBNS-deficient LDLr −/− mice compared with those fed a cholate-free HFD (HFD(CA (−))).
Materials and methods

Animals
The generation of LDLr −/− mice that lacked IκBNS (IκBNS
) used in this study has been described previously [24] . Details of IκBNS-deficient mice were described in the previous report [3] . We used 8 to 12 week old male LDLr −/− and IκBNS
/LDLr −/− mice. We investigated atherosclerotic lesions in both mice after 6-week consumption of HFD(CA(+)), which included 16% fats in the form soy bean oil, cocoa butter, and coconut oil, 1.25% cholesterol, and 0.5% sodium cholate (D12336, Research Diets, New Brunswick, NJ) or HFD(CA(−)) (99020201, Research Diets). The mice were randomly divided into 4
mice. This study was performed according to the protocols approved by the Juntendo University Board for Studies in Experimental Animals.
Quantification of atherosclerotic lesions
After measuring systolic blood pressure, mice were euthanized by pentobarbital injection, and the heart and aorta were flushed with 0.9% NaCl followed by 4% paraformaldehyde. After perfusion procedure, the aorta was harvested and fixed with 10% neutral buffered formalin for 48 h, embedded in paraffin, and sectioned from just above the aortic valve throughout the aortic sinus (each 6 μm thickness). We used equally spaced 5 cross sections (100 μm interval) from the initial appearance of the aortic valves to quantify atherosclerotic lesions in the aortic sinus for each mouse. The samples were stained with Elastica van Gieson, and then photographed using a BX53 microscope (OLYM-PUS, Tokyo, Japan). The luminal, atherosclerotic lesions and vascular area were calculated using ImageJ 1.51j8 (National Institute of Health, Bethesda, MD). Quantification of the atherosclerotic lesions was performed by two blinded observers.
The whole aortas were also stained with Sudan IV. The surface atherosclerotic lesions were expressed as the percent of the lesion area extending from the ascending aorta to the iliac bifurcation.
Immunohistochemistry
Immunohistochemical detection was done with a Discovery XT stainer (Ventana Medical Systems, Tucson, AZ). After blocking endogenous peroxidase activity and revitalizing the tissue antigens with CC1 buffer, the following primary antibodies were applied: monoclonal rat anti-mouse Mac-3 (BD Biosciences, San Jose, CA), monoclonal rat antimouse TLR4 (Santa Cruz Biotechnology, Santa Cruz, CA), polyclonal rabbit anti-mouse IL-6 (Abcam, Cambridge, MA) and monoclonal rabbit anti-mouse phospho-STAT3 (pSTAT3) (Cell Signaling Technology, Danvers, MA). Antigens were visualized with the staining system, iView DAB Detection Kit (Ventana Medical Systems), and with hematoxylin counterstaining. The ratio of the positive staining area for Mac-3, TLR4 and IL-6 to vascular area were quantified using the KS400 Carl Zeiss image analysis system (Carl Zeiss Imaging Solutions GmbH, Hallbergmoos, Germany). The percentage of pSTAT3 positive nuclei in the vascular wall of the aortic root were quantified using the ImageJ 1.51j8.
Plasma cytokine measurement
IL-6 levels in plasma were measured by enzyme-linked immunosorbent assay (ELISA) (BioLegend, San Diego, CA) following the manufacturer's instructions.
Blood cell analysis
Blood was collected from the tail vein, lysed using red blood cell lysis buffer (BioLegend). Cells were washed in FACS buffer (0.2%FBS in PBS) and non-specific binding sites were blocked by incubating 15 min at 4°C with a Fc-blocking antibody (anti-CD16/32, clone 2.4G2, BD Biosciences). Next, cell suspensions were stained for 30 min at 4°C with the following fluorescent conjugated antibodies: CD45 PE-Cy7 (clone 30-F11, BD Biosciences), CD11b FITC (clone M1/70, BioLegend), CD115 APC (clone AFS98, BioLegend), Ly6C PE (clone HK1.4, BioLegend). Following washing with FACS buffer they were analyzed on a FACS CantoII flow cytometer (BD Biosciences) and data was processed using FACS Diva and FlowJo software (BD Biosciences).
Statistical analysis
Statistical analysis was performed using GraphPad Prism 7 software (GraphPad Software, La Jolla, CA). Two-way ANOVA tests were used to evaluate statistically significant differences between multiple groups, after which Tukey tests were performed for paired comparisons if the multiple group comparison indicated a difference between groups. Results were considered statistically significant at p b 0.05. mice were also significantly larger than those in others after 6-week consumption of HFD (p b 0.05) (Fig. 1B) . HFD(CA(−)) also did not induce significant atherosclerotic lesions in IκBNS
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with LDLr −/− mice after 6-week consumption (Fig. 1B) . These results
show that only IκBNS −/− /LDLr −/− mice induce significant atherosclerotic lesions after 6-week consumption of HFD(CA(+)).
HFD(CA(+)) significantly promotes macrophage accumulation in the aorta of IκBNS
To examine the accumulation of inflammatory cells of the aortic root after 6-week consumption of HFD(CA(+)) or HFD(CA(−)), we performed immunohistochemistry for macrophages (Mac-3) (Fig. 2A) . (CA(−)) mice (21.7 ± 1.5 (n = 10) vs. 21.2 ± 2.1% (n = 7); not significant) (Fig. 2B) . These results indicate that HFD(CA(+)) also promotes accumulation of macrophages in IκBNS-deficient LDLr −/− mice. To evaluate the expressions of TLR4, IL-6, and pSTAT3 of the aortic root after 6-week consumption of HFD(CA(+)) or HFD(CA(−)), we performed immunohistochemistry for these proteins. After 6-week consumption of HFD(CA(−)), we detected no significant differences in the expressions of these three proteins between LDLr 15.3 ± 2.7% (n = 7); p b 0.05) (Fig. 3A) . IL-6 protein expression in the aorta of IκBNS −/− /LDLr −/− (CA(+)) was also significantly stronger than that of LDLr −/− (CA(+)) mice (22.4 ± 1.5 (n = 8) vs. 13.1 ± 2.2% (n = 7); p b 0.05) (Fig. 3B) . Furthermore, the percentages of pSTAT3 positive cells in the aorta of IκBNS To examine the plasma levels of IL-6 after 6-week consumption of HFD(CA(+)) or HFD(CA(−)), we analyzed blood samples from all (CA(−)) mice (5.6 ± 1.5 (n = 8) vs. 5.8 ± 0.8 pg/mL (n = 12); not significant) (Fig. 3D) . These findings suggest that the high plasma IL-6 levels in IκBNS (CA(+)) mice, we investigated whether IκBNS might be involved in the regulation of monocyte phenotypic switch after consumption of HFD(CA (+)). To test this, we have determined the monocyte subsets in the peripheral blood from the four groups. We found that the percentages of Ly6C (CA(+)) mice (Fig. 4) . These findings reveal that lack of IκBNS enhances inflammation in response to HFD(CA (+)) feeding and thereby influence atherogenesis in IκBNS −/− / LDLr −/− (CA(+)) mice.
Discussion
Although NF-κB protein induces the expression of different inflammatory cytokines in macrophages, IκBNS selectively suppresses the expression of LPS-induced IL-6 in macrophages [11] . IκBNS deficient mice are highly susceptible to LPS-induced endotoxin shock and inflammatory bowel disease, which was mediated by TLR signaling pathway [3] . Taken together, IκBNS regulates the expression of TLR-related genes via regulation of NF-κB activity [3] . Furthermore, IL-6/STAT pathway modulates LPS/TLR4-driven inflammatory responses, overactivation of STAT3 upregulates IL-6 production directly and via TLR4 signaling [25] . These findings indicate that stimulation of innate immunity should promote TLR4-induced inflammation in the IκBNS-deficient mice. However all IκBNS-deficient mice died within 4 days of LPS challenge at a dose of which almost all wild-type mice survived over 4 days [3] , and we decided to use HFD(CA(+)) which has been shown to induce TLR4 mediated early inflammatory response [22] . Other report demonstrated that expression of TLR4 in atherosclerotic plaques of apoE−/− mice fed HFD(CA(+)) (Paigen diet) increases [23] . We, thus, tried to see if the stimulation of innate immunity using HFD(CA(+)) could promote inflammation and development of atherosclerosis in IκBNS HFD(CA(−)) for 6 weeks which is consistent with the results of our previous study [24] . Furthermore, immunohistochemical analysis revealed that HFD(CA(+)) significantly increased the expression levels of TLR4, IL-6, and pSTAT3 in atherosclerotic plaques in IκBNS We also showed that plasma levels of IL-6 in IκBNS −/− /LDLr −/− mice fed HFD(CA(+)) were significantly increased compared with LDLr −/− mice fed the diet after 6 weeks, whereas plasma levels of IL-6
were not different between LDLr −/− and IκBNS −/− /LDLr −/− mice after consumption of HFD(CA(−)) for 6 weeks which is consistent with our preliminary study. Previous study showed IκBNS −/− mice injected intraperitoneally with LPS increased serum levels of IL-6 compared with wild-type mice [3] . These findings suggest that HFD(CA (+)) induces systemic inflammation in IκBNS −/− /LDLr −/− mice similarly to LPS injection through the TLR4 signaling pathway. As a result, HFD(CA(+)) induces not only the local increase of IL-6 protein expression in atherosclerotic lesions but also plasma levels of IL-6. We think that the increase in IL-6 must also contribute to the development of atherosclerotic lesions. Indeed, previous study demonstrated that injection of IL-6 accelerated atherosclerosis in both apoE −/− and wild-type mice,
indicating that IL-6 has a significant atherogenic effect [26] . Circulating monocytes in mice can be classified into Ly6C hi and Ly6C lo subsets based on the expression levels of Ly6C [27] [28] [29] . Previous reports showed that Ly6C hi monocytes mobilize more rapidly to sites of inflammation such as atherosclerotic plaques than Ly6C lo monocytes do [29] [30] [31] [32] . In both LDLr −/− and IκBNS ) induces an early inflammatory response via TLR4 [22] . (ii) Lack of IκBNS upregulates TLR4 expression and NF-κB activity, and promotes induction of TLR4-dependent genes including IL-6 after HFD(CA(+)) feeding. (iii) STAT3 activation has been in atherosclerotic lesions [34] , and its activation is involved in the development of atherosclerosis [35] . In the present study, IL-6 expression and STAT3 activation were increased in the foam cell rich-atherosclerotic lesions of IκBNS −/− /LDLr −/− mice at only 6 weeks after consumption of HFD(CA(+)), indicating that deficiency of IκBNS promoted both inflammation and development of atherosclerotic lesions via the TLR4/IL-6/STAT3 signaling pathway. NF-κB and its regulator IκB proteins participate importantly in the regulation of host immune responses. In this study, we elucidated the role of IκBNS that participates in HFD(CA(+))-induced inflammation.
In conclusion, IκBNS −/− /LDLr −/− mice showed significant development of atherosclerosis at only 6 weeks after consumption of HFD(CA(+)).
We revealed the effect of overactivation of inflammatory pathway such as TLR4/IL-6/STAT3 pathway caused by disruption of innate immune suppression on atherogenesis. These findings may lead to identification of new therapeutic targets in the treatment of atherosclerosis.
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